Joseph E. LoConti 13D and 13G filings for Valion Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-25 4:17 pm Purchase | 2025-09-23 | 13D | VITALITY BIOPHARMA INC VBIO | Joseph E. LoConti | 1,065,832 23.730% | 98,454 (+10.18%) | Filing |
| 2025-01-23 4:10 pm Sale | 2025-01-21 | 13D | VITALITY BIOPHARMA INC VBIO | Joseph E. LoConti | 967,378 22.400% | -101,438 (-9.49%) | Filing |